CCL2 and atherosclerosis: The difference from our paper is the additional investigation of the monocyte chemotrained protein-1 (MCP-1) pathway, a type of chemokine that moves and attaches monocytes, which play an important role in the early stages of atherosclerosis, as well as anti-inflammation.